Nutrition therapy in peanut allergy

被引:0
|
作者
Reese I. [1 ,2 ]
Schnadt S. [1 ,2 ]
机构
[1] Ernährungsberatung und -therapie Schwerpunkt Allergologie, Ansprenger Straße 19, Munich
[2] Deutscher Allergie- und Asthmabund e. V., Mönchengladbach
关键词
Avoidance; Disease management; Education; LMIV; Risk assessment;
D O I
10.1007/s40629-021-00176-4
中图分类号
学科分类号
摘要
Background: The diagnosis “peanut allergy” is often frightening for affected persons and their families because it is perceived as life-threatening much more often than allergies to other foods. In order to be able to realistically assess risks, alleviate or dispel emerging concerns, and effectively counteract the feeling of being powerless over this diagnosis, good education, integration of affected families into existing structures, and their support in everyday life are needed. Results and discussion: Effective disease management in (peanut) allergy is based on four pillars: (a) a confirmed diagnosis, (b) knowledge about the occurrence of peanut—especially in processed form, (c) situational risk assessment as a basis for individual avoidance strategies that promise the greatest possible safety, but at the same time do not restrict the quality of life more than necessary, and (d) learning to deal adequately with unforeseen incidents (emergency management) to avoid severe allergic reactions. Conclusion: This requires close cooperation between pediatricians or allergists, allergy-experienced nutritionists or dieticians and ideally psychologists. Furthermore, the membership of a patient organization and the participation of affected persons and their environment in training measures (e.g. anaphylaxis training) is useful. © 2021, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码:282 / 286
页数:4
相关论文
共 50 条
  • [41] Peanut Allergy In Ireland
    Hughes, J. L.
    Brown, T.
    Edgar, D.
    Hourihane, J. O.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S109 - S109
  • [42] Propofol and peanut allergy
    Gangineni, K.
    Scase, A. E.
    Fearn, J.
    ANAESTHESIA, 2007, 62 (11) : 1191 - 1191
  • [43] Peanut allergy.
    Dutau, G
    Rancé, F
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2001, 41 (02): : 187 - 198
  • [44] Peanut allergy illuminated
    Stephenson, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14): : 1774 - 1774
  • [45] Peanut Allergy Prevention
    Volerman, Anna
    Cifu, Adam S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (09): : 927 - 928
  • [46] Recurrent peanut allergy
    Busse, PJ
    Nowak-Wegrzyn, AH
    Noone, SA
    Sampson, HA
    Sicherer, SH
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (19): : 1535 - 1536
  • [47] Peanut allergy in twins
    Sicherer, SH
    Furlong, TJ
    Gelb, BD
    Desnick, RJ
    Sampson, HA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S181 - S181
  • [48] Hope for peanut allergy?
    Jenny Buckand
    Nature Reviews Immunology, 2003, 3 (8) : 601 - 601
  • [49] Preventing peanut allergy
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (05)
  • [50] The management of peanut allergy
    Anagnostou, Katherine
    Clark, Andrew
    ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (01) : 68 - 72